Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.35 |
| ▸ | IDH1 | O75874 | 2/20 | 0.35 |
| ▸ | IDH2 | P48735 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | IGF1R | P08069 | 2/20 | 0.31 |
| ▸ | BRS3 | P32247 | 2/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.31 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.31 |
| ▸ | VCP | P55072 | 1/20 | 0.30 |
| ▸ | TPH1 | P17752 | 1/20 | 0.30 |
| ▸ | ENO1 | P06733 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24933040 | 0.84 | LMNA (0.42) | CNR2HRH4IDH1VCP | |
| SCHEMBL25868870 | 0.78 | VCP (0.44) | CNR2VCPTPH1ENO1 | |
| SCHEMBL24724734 | 0.78 | TPH1 (0.39) | CNR2HRH4IDH1IDH2CNR1 | |
| SCHEMBL24724733 | 0.77 | ALDH1A1 (0.46) | CNR2VCPTPH1ENO1 | |
| SCHEMBL21479645 | 0.76 | HDAC6 (0.40) | CNR2BRS3VCPTPH1ENO1 | |
| SCHEMBL23346071 | 0.76 | HDAC6 (0.40) | CNR2IDH1IDH2CNR1BRS3 | |
| SCHEMBL13607364 | 0.70 | ENO1 (0.55) | ENO1 | |
| SCHEMBL23386772 | 0.70 | ENO1 (0.55) | ENO1 | |
| SCHEMBL4829259 | 0.69 | GALR1 (0.58) | CNR2IDH1CNR1ENO1 | |
| SCHEMBL8054361 | 0.65 | IDH1 (0.46) | IDH1IDH2PTGS2RETTPH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022235699-A2 | POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2022-11-10 | — | — | WO | disclosed |